Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced NSCLC × Oxaliplatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 445 Stomach Neoplasms 295 Rectal Neoplasms 269 Colonic Neoplasms 191 Pancreatic Neoplasms 174 Neoplasm Metastasis 110 Esophageal Neoplasms 87 Neoplasms 68 Carcinoma, Hepatocellular 60 Adenocarcinoma Of Esophagus 46 Adenocarcinoma 46 Cholangiocarcinoma 45 Lymphoma, Large B-Cell, Diffuse 43 Carcinoma, Non-Small-Cell Lung 41 Biliary Tract Neoplasms 36 Gallbladder Neoplasms 31 Gastrointestinal Neoplasms 29 Recurrence 25 Liver Neoplasms 25 Ovarian Neoplasms 23 Esophageal Squamous Cell Carcinoma 22 Breast Neoplasms 22 Peritoneal Neoplasms 18 Bile Duct Neoplasms 17 Unspecified Adult Solid Tumor, Protocol Specific 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Head and Neck Neoplasms 13 Lung Neoplasms 12 Locally Advanced Rectal Cancer 12 Colorectal Cancer Metastatic 11

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 famitinib 1 camrelizumab 1 aflutinib 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡